Patent · US Active

MiRNA biomarkers of prostate disease

US8597892B2 · kind B2 · utility

4Cited by

1References

9Claims

0Family size

Assignee

ASURAGEN, INC. · US

Inventors

Jeffrey Shelton · Los Angeles, US
Kevin Kelnar · Kyle, US
Stephanie Volz · Austin, US
Alex Adai · Austin, US
David Brown · Brighton, US

Key dates

Filing date	May 21, 2010
Grant date	Dec 3, 2013
Priority date	—
Expiry date	Aug 23, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.